The impact of Pandemic COVID-19 on cases of Borreliosis infection in 2020
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.029Keywords
Lyme borreliosis, Lyme disease, Poland, epidemiologyAbstract
Borreliosis (Lyme borreliosis; Lyme disease) is a zoonotic disease caused by spirochetes from the genus Borrelia. In humans, the accidental host of ticks, the infection is transmitted by the bite of the tick - the spirochetes are present in the salivary glands of the tick. Any of the three forms of tick: larva, nymph and adult can be responsible for infection. The most common threats to humans are Borrelia burgdorferii sensu stricto, Borrelia garinii and Borrelia afzelii occurring mainly in Europe. Lyme disease is a complex, multi-stage disease and progresses in 3 stages. The targeted treatment of Lyme disease is based on the administration of antibiotics. The introduction of antibiotics in the early stages of Lyme borreliosis offers a good chance of a complete cure. Lyme disease is a major epidemiological problem in the world. In Europe, the average number of cases per year remains at 65,400. In Poland, the number of infections annually reaches several tens of thousands. According to the National Institute of Hygiene of Poland, which keeps statistics of epidemiological reports, a total of 83,495 people fell sick with Lyme disease in Poland between 2016 and 2019. Whereas in 2020, the number of cases of Lyme disease decreased to 12933. The reason for this is undoubtedly the COVID-19 pandemic, which has dominated health care and focused all the attention of medical workers. This review shows that Lyme borreliosis is a dangerous disease with a high risk of complications. A quick diagnosis is crucial in the therapeutic process. An algorithm should be developed in order to distinguish other diseases from Lyme disease and thus enable an early reaction and treatment.
References
Aucott, J., & Seifter, A. (2011). Misdiagnosis of early Lyme disease as the summer flu. Orthopedic Reviews, 3(2), 14. https://doi.org/10.4081/OR.2011.E14
Belongia, E., Reed, K., Mitchell, P., Mueller-Rizner, N., Vandermause, M., Finkel, M., & Kazmierczak, J. (2001). Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 32(10), 1434–1439. https://doi.org/10.1086/320160
Borchers, A. T., Keen, C. L., Huntley, A. C., & Gershwin, M. E. (2015). Lyme disease: A rigorous review of diagnostic criteria and treatment. Journal of Autoimmunity, 57, 82–115. https://doi.org/10.1016/J.JAUT.2014.09.004
Cameron, D. J., Johnson, L. B., & Maloney, E. L. (2014). Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Review of Anti-Infective Therapy, 12(9), 1103. https://doi.org/10.1586/14787210.2014.940900
Cuvelier, M., Leonard, P., Rikir, E., Huynen, R., & Sadzot, B. (2008). Neuroborreliosis. Rev Med Liege ., 63(5–6), 349–353.
Felsenfeld, O. (1971). Borrelia: strains, vectors, human and animal borreliosis. Borrelia: Strains, Vectors, Human and Animal Borreliosis., 75(5), 822–824. https://doi.org/https://doi.org/10.7326/0003-4819-75-5-822_4
Flisak, R., & Pancewicz, S. (2008). Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases. Przegląd Epidemiologiczny, 62(1), 193–199.
Garcia-Monco, J. C., & Benach, J. L. (2019). Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections. Annals of Neurology, 85(1), 21. https://doi.org/10.1002/ANA.25389
Liang, L., Wang, J., Schorter, L., Trong, T. P. N., Fell, S., Ulrich, S., & Straubinger, R. K. (2020). Rapid clearance of Borrelia burgdorferi from the blood circulation. Parasites & Vectors, 13(1), 191. https://doi.org/10.1186/S13071-020-04060-Y
National Institute of Hygiene of Poland. (2021). Biuletyny, meldunki, informacje epidemiologiczne. Retrieved September 12, 2021, from http://wwwold.pzh.gov.pl/oldpage/epimeld/index_p.html
Rizzoli, A., Hauffe, H. C., Carpi, G., Vourc’h, G. I., Neteler, M., & Rosà, R. (2011). Lyme borreliosis in Europe. Eurosurveillance, 16(27), 19906. https://doi.org/10.2807/ESE.16.27.19906-EN
Sprong, H., Azagi, T., Hoornstra, D., Nijhof, A. M., Knorr, S., Baarsma, M. E., & Hovius, J. W. (2018). Control of Lyme borreliosis and other Ixodes ricinus-borne diseases. Parasites & Vectors, 11(1), 145. https://doi.org/10.1186/S13071-018-2744-5
Stanisławska – Biernat E. (2006). Współczesne podejście do diagnostyki i leczenia boreliozy. Terapia, 2, 57–60.
Steere, A., Strle, F., Wormser, G., Hu, L., Branda, J., Hovius, J., … Mead, P. (2016). Lyme borreliosis. Nature Reviews. Disease Primers, 2, 16090. https://doi.org/10.1038/NRDP.2016.90
Tibbles, C., & Edlow, J. (2007). Does this patient have erythema migrans? JAMA, 297(23), 2617–2627. https://doi.org/10.1001/JAMA.297.23.2617
Vasudevan, B., & Chatterjee, M. (2013). Lyme borreliosis and skin. Indian Journal of Dermatology, 58(3), 167–174. https://doi.org/10.4103/0019-5154.110822
Wormser, G. (2006). Clinical practice. Early Lyme disease. The New England Journal of Medicine, 354(26), 2794–2801. https://doi.org/10.1056/NEJMCP061181
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 621
Number of citations: 0
